Shell Asset Management CO Ligand Pharmaceuticals Inc Transaction History

Shell Asset Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$99.52 - $215.83 $366,333 - $794,470	-3,681 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$68.28 - $123.65 $31,818 - $57,620	466 Added 14.49%	3,681 $412,000
Q1 2020 May 11, 2020	SELL	$63.37 - $107.88 $3,168 - $5,394	-50 Reduced 1.53%	3,215 $234,000
Q4 2019 Feb 13, 2020	SELL	$96.94 - $113.59 $11,923 - $13,971	-123 Reduced 3.63%	3,265 $341,000
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $2,501 - $3,484	-29 Reduced 0.85%	3,388 $337,000
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $8,375 - $10,088	-78 Reduced 2.23%	3,417 $390,000
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $38,508 - $81,639	-300 Reduced 7.91%	3,495 $474,000
Q3 2018 Nov 13, 2018	BUY	$211.18 - $274.49 $801,428 - $1.04 Million	3,795 New	3,795 $1.04 Million

275

18.5M

28.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.03B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.